Autonomix Medical (AMIX) Non Operating Investment Income (2023 - 2024)

Autonomix Medical (AMIX) reported Non Operating Investment Income of -$4.6 million for Q1 2024, little changed quarter-over-quarter from -$4.6 million in Q3 2023.

Autonomix Medical (AMIX) Non Operating Investment Income (2023 - 2024) Analysis & Trends

Autonomix Medical (AMIX) has 2 years of Non Operating Investment Income data on file, last reported at -$4.6 million in Q1 2024.

  • Non Operating Investment Income for Q1 2024 came in at -$4.6 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2025 was -$4.6 million (changed N/A YoY), and the FY2024 annual result was -$4.6 million, changed N/A from the prior year.
  • Non Operating Investment Income was little changed at -$4.6 million in Q1 2024 per AMIX's latest filing, from -$4.6 million in the prior quarter.
  • Over five years, Non Operating Investment Income peaked at -$4.6 million in Q3 2023 and troughed at -$4.6 million in Q3 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Investment Income (Qtr)
1 Abbott Laboratories 152.92 Bn 146.27 Bn 6.27 Bn -
2 Stryker 119.50 Bn 116.62 Bn 3.81 Bn -
3 Medtronic 102.71 Bn 94.54 Bn 5.76 Bn -
4 Boston Scientific 69.72 Bn 68.51 Bn 3.61 Bn -
5 Edwards Lifesciences 49.24 Bn 45.57 Bn 1.29 Bn -
6 GE HealthCare Technologies 29.74 Bn 27.67 Bn 1.98 Bn -
7 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
8 Dexcom 28.96 Bn 27.84 Bn 750.30 Mn -
9 Steris 20.31 Bn 19.88 Bn 697.10 Mn -
10 Autonomix Medical 3.33 Mn 3.33 Mn - -

Historic Data

Download Data
DateValue
Mar 31, 2024 -4.56 Mn
Mar 31, 2024 -4.56 Mn
Sep 30, 2023 -4.56 Mn
Sep 30, 2023 -4.56 Mn